Advancing today’s discoveries to improve health for all.

Winn Career Development Award (Winn CDA) Accepting Applications

The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) is a $124.5 million initiative funded by the Bristol Myers Squibb Foundation, Gilead Sciences, Amgen and Genentech and led by a team at the Virginia Commonwealth University's Massey Comprehensive Cancer Center.

Winn awards logo

The Winn Awards program is designed to improve participation in clinical trials to drive better health outcomes in all communities to save more lives. The applications are open for one of their signature programs: the Winn Career Development Award (Winn CDA). 

Winn CDA is a two year program designed to support the career development of early-stage investigator physicians who have a demonstrated commitment to transforming and expanding access to the clinical research landscape. They will become community-oriented clinical trialists who will drive improved health outcomes through their research and mentoring.

This award is open to early-career physician researchers who are committed to improving patient participation in clinical trials and transforming the clinical trials.

Applications will be accepted through Monday, May 12, 2025.

Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.